Join Now

Author Archives: Press Release

2024 ULSS Recap

By Press Release | Published November 14, 2024

BioUtah yesterday held its 2024 Utah Life Sciences Summit, sponsored by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. A distinguished line-up of industry leaders and inspiring speakers addressed a packed house. Utah Governor Spencer Cox welcomed attendees to kick off the day-long […]

Posted in BioUtah News | Tagged | Comments Off on 2024 ULSS Recap

Ross Southern Laboratories achieves certification to ISO 9001

By Press Release | Published November 14, 2024

Ross Southern Laboratories (RSL) proudly announces its ISO 9001 certification for its Quality Management System

Posted in BioUtah News | Tagged | Comments Off on Ross Southern Laboratories achieves certification to ISO 9001

UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

By Press Release | Published September 5, 2024

Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.

Posted in Policy News | Tagged | Comments Off on UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

BD Completes Acquisition of Critical Care from Edwards Lifesciences

By Press Release | Published September 5, 2024

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.

Posted in BioUtah News | Tagged , | Comments Off on BD Completes Acquisition of Critical Care from Edwards Lifesciences

Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

By Press Release | Published September 5, 2024

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.

Posted in BioUtah News | Tagged | Comments Off on Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

By Press Release | Published September 5, 2024

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.

Posted in BioUtah News | Tagged | Comments Off on Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

By Press Release | Published September 5, 2024

Edwards Lifesciences announced the results from the RHEIA Trial.

Posted in BioUtah News | Tagged | Comments Off on FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

By Press Release | Published September 5, 2024

Halia Therapeutics’ CEO, David Bearss, recently discussed the FDA’s Project Optimus in The Wall Street Journal.

Posted in BioUtah News | Tagged | Comments Off on Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

By Press Release | Published June 27, 2024

Transformative Angioplasty Sheath Platform Compatible with a Broad Range of Off-the-Shelf PTA and PTCA Angioplasty Balloons Cleared by FDA

Posted in BioUtah News | Tagged | Comments Off on FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

Renew Biotechnologies

By Press Release | Published June 27, 2024

Renew Biotechnologies is a dynamic holding company dedicated to acquiring, developing, and commercializing impactful biotechnology.

Posted in BioUtah News | Tagged | Comments Off on Renew Biotechnologies

BioUtah Organizes Stryker, bioMérieux Tours for State Legislators

By Press Release | Published June 20, 2024

State legislators got a first hand look at Utah’s life sciences industry.

Posted in BioUtah News | Comments Off on BioUtah Organizes Stryker, bioMérieux Tours for State Legislators

New FDA Cleared Balloon Catheter Used for Vessel Occlusion During Patient Resuscitation

By Press Release | Published June 20, 2024

Temporary vessel occlusion a growing practice for trauma patients.

Posted in BioUtah News | Tagged | Comments Off on New FDA Cleared Balloon Catheter Used for Vessel Occlusion During Patient Resuscitation

A Special Thanks To Our Elite Members